The papillomavirus E5 protein is localized in the endoplasmic reticulum (ER) and Golgi apparatus (GA) of the host cell. Transformed bovine ®broblasts expressing bovine papillomavirus (BPV) E5 are highly vacuolated and have a much enlarged, distorted and fragmented GA. Major histocompatibility complex class I (MHC I) is processed and transported to the cell surface through the GA. Given the cellular localization of E5 in the GA and the morphologically abnormal GA, we investigated the expression of MHC I in cells transformed by E5 from BPV-1 and BPV-4. Two cell lines were used: bovine cells that also express E6, E7 and activated ras, and NIH3T3 cells that express only E5. In addition, PalF cells acutely infected with a recombinant retrovirus expressing E5 were also examined. In contrast to non-transformed normal cells, or transformed cells expressing other papillomavirus proteins, cells expressing E5 do not express MHC I on their surface, but retain it intracellularly, independently of the presence of other viral or cellular oncogenes, or of whether the cells are long-term transformants or acutely infected. We conclude that expression of E5 prevents expression of MHC I to the cell surface and causes its retention within the cell. In addition, lower amounts of total MHC I heavy chain and of heavy chain RNA are detected in E5-transformed cells than in control cells. As surface expression of another glycosylated membrane protein, the transferrin receptor, is not aected, it appears that E5 targets MHC I with at least a degree of speci®city. In papillomavirus lesions this eect would have important implications for antigen presentation by, and immunosurveillance of, virally infected cells.
Introduction
Papillomavirus is an oncogenic virus which infects mucosal and cutaneous epithelia where it induces benign hyperproliferative lesions. In the great majority of cases, papillomavirus infections are usually cleared, after a variable period of time, usually several months, by a cell mediated immune response directed against viral antigens (Frazer and Tindle, 1996) . Occasionally however, the lesions do not regress and can progress to cancer. Persistent viral infection is required for neoplastic progression and failure of virus clearance is attributed to a poor immunological response.
The papillomavirus genome encodes three proteins, E5, E6 and E7, capable of inducing unscheduled proliferation of keratinocytes. All three proteins can transform cells in vitro, although their contribution to cell transformation appears to vary in dierent virus types. While E6 and E7 are the main oncoproteins of mucosal HPVs (Kubbutat and Vousden, 1996; Kunhe and Banks, 1999) , E5 is the major oncoprotein of BPVs, particularly of BPV-1. The E5 protein, and the closely related E8 protein of subgroup B bovine papillomaviruses (BPV), therein collectively designated E5 (Morgan and Campo, 2000) , is a small hydrophobic peptide (from 83 amino acid residues in human papillomavirus type 16 to 42 residues in BPV-4) which is expressed in the deep layers of the infected epithelium (Anderson et al., 1997; Burnett et al., 1992; Chang et al., 2001) . While E6 and E7 are present throughout the course of the disease and their functions are necessary for the maintenance of a transformed state, expression of E5 takes place early in infection, and is often, but not always (Chang et al., 2001) , extinguished in frank cancers. In genital lesions induced by mucosal HPV, the expression of E5 is extinguished as the lesion progresses to malignancy, due to the frequent occurrence of the integration of the viral genome into the host chromosome at the E2/E5 open reading frame (ORF); in the lesions induced by BPV the mechanisms that silence the expression of E5 from an intact episomal genome are not known.
E5 is localized in the endomembrane compartments of the endoplasmic reticulum (ER) and Golgi apparatus (GA) of the host cell (Burkhardt et al., 1989; Pennie et al., 1993) . BPV-4 E5 induces anchorage independence (Pennie et al., 1993) , allows cell growth in low serum, prevents contact inhibition (Ashra® et al., 2000; O'Brien et al., 1999) and down-regulates gap junction communication (Ashra® et al., 2000; Faccini et al., 1996) . The ability of the E5 expressing cells to grow independent of substrate and in low serum is accompanied and likely due to activation of cyclin A-cdk2 (O'Brien and Campo, 1998) , while the down-regulation of gap junction communication, observed also in cells expressing HPV-16 E5 (Oelze et al., 1995) , is accompanied by binding of E5 to the 16 k ductin/subunit c, a component of the gap junction and of the V0 sector of the vacuolar H + -ATPase (Finbow et al., 1991; Goldstein et al., 1991; Conrad et al., 1993; Faccini et al., 1996) . This physical interaction has been deemed responsible also for the lack of acidi®cation of endosomes and GA (Schapiro et al., 2000; Straight et al., 1995) , which has been attributed to a malfunction of the H + -ATPase (Briggs et al., 2001) , although inhibition of the vacuolar proton pump is not always observed (Ashby et al., 2001) . Cellular transformation by E5 is also accompanied by the activation of growth factor receptors (Martin et al., 1989; Petti et al., 1991; Leechanachai et al., 1992; Straight et al., 1993) and other kinases (Gu and Matlashewski, 1995; Crusius et al., 1999; Suprynowicz et al., 2000) . It is reasonable to assume that the various aspects of cell transformation by such a small protein may all derive from its very location in the endomembrane compartment, particularly the GA, with the putative consequent disruption of exocytic and endocytic cellular trac, including transport of the MHC I complex.
Recognition and elimination of virally infected cells by T-lymphocytes require presentation of viral peptides by the MHC class I complex. Peptides are loaded onto the MHC I heavy chain in the ER, where b2-microglobulin and chaperones, such as TAP, associate with the complex. MHC I is glycosylated as the complex is transported from the ER through the GA to the plasma membrane for recognition by T-cells (Cresswell et al., 1999) . Deglucosylation in the GA is necessary for the dissociation of MHC I from both calreticulin and TAP peptide transport molecules (Van Leeuwen and Kearse, 1996) . In addition, the assembly of the MHC I complex with peptide is pH dependent (Reich et al., 1997) . Therefore, given the cellular location of E5 in cell membranes and the attendant inhibition of membrane compartment acidi®cation, we investigated whether MHC I would be properly transported to the cell surface. We report that in E5-expressing cells MHC I is down-regulated and retained intracellularly, thus adding yet another function to the pleiotropic action of this protein.
Results

Morphology of Golgi apparatus in PalF cells
As reported previously (Ashra® et al., 2000) , the E5-expressing transformed PalF cells were very enlarged and highly vacuolated (Figure 1a ). Vacuole formation takes place only in the presence of the full transforming forms of E5. The vacuoles are compartmentalized, with vacuoles communicating within but not between compartments as shown by the distribution of thē uorescent dye lucifer yellow injected into single cells (Ashra® et al., 2000) .
E5 inhibits acidi®cation of the endomembrane compartments, and it is known that the inhibition of acidi®cation of endomembrane compartments by ionophores leads to fragmentation of the Golgi apparatus. Therefore, to investigate the origin of the vacuoles in E5 cells, we visualized the GA by immuno¯uorescence. Monoclonal antibody (mAb) 4A3 is raised against GM130, an integral component protein of Golgi membranes (Barr et al., 1998) . When PalF cells or transformed control cells were incubated with mAb 4A3 the GA showed a normal morphology (Figure 1b ). In the E5-expressing cells, the GA showed a disrupted architecture and numerous vacuoles had reacted with the antibody (Figure 1c ). Often only vacuoles were stained ( Figure 1c , left panel). Similar results were obtained when the GA was stained with uorescent BODIPY-ceramide, which localizes to the Golgi membranes, or when it was visualized by electronmicroscopy (data not shown). These results suggest that at least some of the vacuoles in E5 cells are derived from the fragmentation of the Golgi cisternae. The fragmentation of the GA in E5 cells does not appear to be a consequence of long-term culturing as in approximately one-third of PalF cells acutely infected with a recombinant retrovirus expressing BPV-4 E5 (see below) the GA was enlarged, when compared with cells infected with the control retro- (g,h) were stained with mAb IL-A19 and analysed by¯ow cytometry. Surface MHC I was measured in intact cells (a,c,e,g ) and total MHC I was measured in saponin-permeabilized cells (b,d,f,h) virus, although not as distorted as in long-term E5 transformants (data not shown).
Morphology of Golgi apparatus in NIH3T3 cells
To ascertain the state of the GA in cells other than PalF cells, we investigated the morphology of the GA in NIH3T3 cells expressing BPV-4 E5 using mAb 4A3. Despite the alkaline pH of the GA in the 3T3 E5 cells (R Schlegel and S Campo, unpublished observations), there were no obvious structural abnormalities between the GA in control NIH3T3 and that detected in the E5 cells (data not shown). This suggests that the abnormal GA morphology observed in PalF cells expressing E5 may be cell type dependent.
MHC class I on the cell surface
Given the abnormal morphology of the ER and GA in E5-expressing PalF cells, and given the importance of these structures in protein trac, we investigated whether E5 expression would disrupt protein transport and in particular MHC I transport to the cell surface. Parental PalF and transformed control cells were incubated with IL-A19, a monoclonal antibody recognizing a monomorphic determinant of the bovine MHC class I complex (Bensaid et al., 1989) and analysed by¯ow cytometry. Both cell lines displayed MHC I on their surface as shown by the increase in relative¯uorescence intensity in the presence of mAb IL-A19 (Figure 2a,c) . In contrast, there was no shift in uorescence in the transformed cells expressing E5 (Figure 2e ,g) indicating that these cells do not present MHC I on their surface. To investigate if this was due to a defect in MHC I transport to the cell surface, the cells were permeabilized with saponin before staining to allow the penetration of the antibody inside the cells and therefore measuring the total MHC I content. The permeabilized parental and transformed control cells exhibited a similar staining pro®le, not dierent from that obtained for surface MHC I (Figure 2b,d ). In contrast, the FACS pro®les for the permeabilized E5 cells showed a positive staining for MHC I ( Figure  2f ,h), indicating that in these cells MHC I was retained intracellularly and was not transported to the plasma membrane. However, the intensity of¯uorescence and the mean¯uorescence of the E5 permeabilized cells were also noticeably reduced when compared to the parental or transformed control cells (Figures 2f,h and 7a), indicative of reduced levels of total MHC I in E5 cells.
Levels of total MHC class I
The FACS analyses above suggested a reduced level not only of surface but also of total MHC I in E5 transformed cells. To con®rm this observation, the amount of total MHC I in the control and transformed cell lines was investigated by immunoblotting using mAb IL-A88, speci®c for a monomorphic determinant on the bovine MHC I heavy chain (Toye et al., 1990) .
While the MHC I heavy chain was easily detectable in PalF and control cells, little MHC I could be detected in the 1-E5 or 4-E5 cells when high amounts of protein were used (Figure 3a) , con®rming that E5 downregulates expression of MHC I. The dierence in sensitivity of detection of total MHC I in E5-expressing cells by FACS or immunoblotting is likely to be due to the dierent anities of IL-A19 and IL-A88 antibodies for the bovine MHC I antigen (data not shown).
Levels of MHC class I transcripts
The noticeable reduction in the levels of MHC I heavy chain could be due to protein degradation, transcription inhibition, rapid RNA degradation or combinations thereof. To ascertain this point, we analysed the level of transcripts encoding the heavy chain of the MHC I complex by semi-quantitative RT ± PCR, using generic oligonucleotide primers that amplify a 733 base-pair (bp) fragment from all classical bovine MHC class I genes and a 533 bp fragment from the corresponding mRNA . As a control we ampli®ed actin cDNA using primers speci®c for bovine actin (Sibbet et al., 2000) . Ampli®cations were carried out for progressively increasing numbers of cycles. While the 273 bp fragment of actin RNA was ampli®ed from both non transformed PalF and 1-E5 transformed cells with similar kinetics (visible on gel after 20 cycles, Figure 3b ), the ampli®cation kinetics of MHC I heavy chain RNA were dierent in PalF and E5-transformed cells. In PalF cells, the expected 533 bp fragment was visible after 20 cycles; in contrast in both 1-E5 and 4-E5 transformed cells the amplicon could not be detected until 25 cycles and in lower amounts ( Figure 3b ). A 733 bp fragment was not detected either in the test reactions or in the control reactions (with no RNA), con®rming that the ampli®cation did not involve genomic DNA. This result shows that the observed down-regulation of MHC I heavy chain protein is not due solely to protein degradation but also to transcription inhibition or RNA degradation.
MHC I on the cell surface in transformed NIH3T3 cells
The transformed PalF cells analysed above express a variety of oncogenes and it could be argued that downregulation of MHC I is due to the interaction of E5 with the E6, E7 or ras oncoproteins. Therefore NIH 3T3 cells expressing only BPV E5 were also analysed for the expression of MHC I. Control 3T3 cells expressed similar levels of surface and total MHC I (Figures 4a,b and 7b) . However, 3T3 4-E5 cells, like the transformed E5 PalF cells, did not express MHC I on the surface but retained it intracellularly ( Figures  4c,d and 7b ). These results show that inhibition of MHC I transport is due to the expression of the E5 protein per se and not to its interaction with other oncoproteins.
However in contrast to the transformed PalF cells, the E5-transformed 3T3 cells did not show any noticeable reduction in total MHC I. The reduction of total MHC I in PalF cells may be due therefore to the combined eects of the viral oncoproteins and/or activated ras, the enlargement and fragmentation of the GA, and to transcriptional down-regulation.
MHC I on the cell surface in PalF cells acutely infected with recombinant retroviruses
The PalF and 3T3 transformed cell lines above are established lines and their long-term culture may have aected the down-regulation of surface MHC I. Hence, PalF cells acutely infected with the recombinant 4-E5 retrovirus were analysed for MHC I expression. Again, these cells showed a marked reduction in surface MHC I ( Figure 5c ) and a less pronounced reduction in total MHC I (Figure 5d ), remarkably similar to that observed in the established transformed cells ( Figure  7a ). This reduction was not observed in PalF cells infected with the control retrovirus (Figure 5a,b) , con®rming that E5 is indeed the cause of the inhibition of MHC I expression.
Transferrin receptor
To ascertain whether the down-regulation of surface MHC I by E5 was speci®c or due to a generalized disturbance in exo-or endocytic protein transport, we analysed cell surface presentation of another membrane glycoprotein, the transferrin receptor. There was no dierence between the total or cell surface amount of transferrin receptor in parental PalF, control or E5 cells ( Figure 6 and data not shown). Therefore synthesis and maturation of glycoproteins is not generally aected in E5 transformed cells, indicating at least a degree of speci®city for the E5 downregulation of MHC I.
Down-regulation of surface MHC I and cell transformation co-segregate
A panel of PalF cell lines expressing mutant forms of the E5 protein (Ashra® et al., 2000) was analysed for down-regulation of surface MHC I. The E5 mutants used here were an hyper-transforming form of BPV-4 E5 in which an asparagine residue at position 17 has been substituted with alanine (N17A); two mutant E5 forms that have completely lost their transformation ability, N17Y, in which residue 17 has been substituted with tyrosine, and the C-terminal truncation mutant E5T, which has no hydrophilic tail, and BPV-1 E5T, a similar C-terminal truncation mutant. Only the hypertransforming mutant of 4-E5 was capable of inhibiting MHC I transport to the cell surface (Figure 7c ). There was no dierence between total and surface MHC I in 
Discussion
During viral infection or malignant transformation, a spectrum of peptides derived intracellularly from viral or transformation-associated antigens is bound to MHC I molecules and displayed on the surface of the infected or tumour cell. These class I/peptide complexes are recognised by speci®c cytotoxic T lymphocytes (CTL), which kill the infected or malignant cells. MHC I molecules therefore play a crucial role in immune recognition and clearance of these types of cell.
Viruses need to escape immunosurveillance by the host to establish infection and to generate new infectious progeny. It is well known that viruses have developed a number of dierent mechanisms to avoid immune recognition by CTL by interfering with various steps of the MHC I pathway, from prevention of peptide processing to formation of non functional MHC I complexes (see Yewdell and Bennink, 1999 for review) . In each of these strategies, the outcome is the failure by the infected cell to present viral peptide antigens to cells of the immune system.
Papillomaviruses are poorly immunogenic. The prolonged absence of an immune response even in immunocompetent hosts has been attributed to a variety of causes (reviewed by Frazer et al., 1999) . The viral proteins are expressed in the suprabasal layers of the epithelium, i.e. in cells not readily exposed to the immune system, and moreover are produced in very low amounts, often below the threshold required for the activation of immune cells, thus leading to tolerance. We report here a possible new mechanism of immune evasion of papillomavirus: the down-regulation of MHC I by the early E5 oncoprotein.
BPV E5 is localized in the endomembrane compartment of the cell. Expression of the protein in primary bovine cells leads to profound changes in cell morphology, with extensive vacuolization (Ashra® ; the GA is particularly aected being grossly distorted, swollen and fragmented. Transformed cells that do not express E5 do not present any apparent GA malformation, so we conclude that it is the presence of the small hydrophobic E5 protein in the GA itself that induces these changes. This conclusion is supported by the swelling of the GA in cells acutely infected with an E5-expressing recombinant retrovirus, a result that also suggests that GA alterations do not depend on the interaction of E5 with the other oncoproteins present in longterm transformants. Interestingly, mutant forms of E5 which have lost or maintain only residual transformation ability do not cause noticeable changes in cell morphology or vacuolisation (Ashra® et al., 2000) . However, gross disruption of the GA does not occur in NIH3T3 cells that express only E5, despite their impaired GA acidi®cation (R Schlegel and S Campo, unpublished observation), so perhaps the morphological alteration of the GA observed in primary bovine cells, the virus natural host, is cell typedependent.
Proper functioning of the Golgi apparatus is necessary for a number of cellular processes including protein transport to the cell surface. MHC I is synthesized in the ER, post-translationally modi®ed in the GA and transported to the plasma membrane (Cresswell et al., 1999) . This process appears to be inhibited in cells expressing E5, which have very little, if any, MHC I on their surface. Down-regulation of surface MHC I takes place both when E5 is expressed with other viral transforming proteins or alone, in long-term transformants or in acutely infected cells, and whether or not the GA has undergone distortion and fragmentation. Therefore, the down-regulation of surface MHC I is due solely to E5 and does not require either other papillomavirus proteins or activated Ras. Moreover, MHC I down-regulation is not con®ned to BPV E5 proteins, as preliminary experiments show that NIH 3T3 cells expressing either HPV-6 or HPV-16 E5 have lower levels of surface MHC I, as do PalF cells acutely infected with a retrovirus expressing HPV-16 E5 (data not shown). Therefore, inhibition of surface MHC I expression appears to be a common character- istic of both HPV and BPV E5 oncoproteins. In addition, there is at least a degree of speci®city in the disturbance of protein trac by E5 as the expression at the cell surface, and presumably the transport, of the transferrin receptor, another membrane glycoprotein, is not aected.
The absence of MHC I on the cell surface appears to be due in part to intracellular retention as MHC I is detected once the cells are permeabilized. There is however, less total MHC I in PalF cells that express E5 than in control cells. We also detected lower levels of MHC I mRNA transcripts in the E5 cells. It is not possible at this stage to ascertain the contribution of transcription inhibition and of protein degradation to the overall down-regulation of MHC I, but it would appear that the reduced levels of MHC I heavy chain protein cannot be solely due to lack of RNA, and it is likely that both processes play a part. However, inhibition of transcription is directly due to E5 expression: the presence of approximately equal amounts of MHC I in parental cells and transformed control cells (expressing E7) argues against transcriptional down-regulation of the heavy chain gene by E7, as recently suggested (Georgopoulos et al., 2000) . Moreover, expression of MHC I in HPV-positive cervical carcinomas, expressing E7 but not E5, has also been shown to be post-transcriptionally controlled (Cromme et al., 1993) .
The reason why the level of total MHC I remains unaltered in E5-expressing NIH3T3 cells remains to be investigated, but it may be linked to the unaltered morphology of the GA in these cells. MHC I may be degraded more rapidly in the grossly distorted GA compartment of PalF cells. This hypothesis is supported by the ®nding that improperly processed MHC I molecules accumulate and are degraded in an expanded ER-Golgi intermediate compartment (Raposo et al., 1995) .
We have not yet determined the mechanism of how E5 expression results in transcriptional inhibition and (O'Brien and Campo, 1998; O'Brien et al., 1999) , although the mechanisms used by this membrane-localized protein to signal to the transcription machinery in the nucleus are not known. The MHC I transport pathway may be blocked in the journey of the peptide/MHC complex to the cell surface, or the MHC complex could be rapidly internalized once it has reached the cell surface. The recognition of MHC I by mAb IL-A19, which detects MHC I heavy chain complexed with b-2 microglobulin (Bensaid et al., 1989) , suggests that the block is a relatively late event in the genesis and transport of MHC I. Therefore, we would expect that inhibition of TAP function (Cromme et al., 1994; Keating et al., 1995) which is responsible for loss of MHC I in pre-malignant and malignant cervical disease (Bontkes et al., 1998; Brady et al., 2000) , and in HPV-associated laryngeal papillomas (Vambutas et al., 2000) , is unlikely to play a role in E5-induced MHC I loss. This is more likely to be a feature of malignancy as observed for other malignant tumours (Seliger et al., 1997) . However, this point remains to be investigated experimentally. Interestingly, HPV-16 E5 has been shown recently to inhibit endocytic tracking (Thomsen et al., 2000) , a ®nding supporting the blocking of MHC I following complex assembly.
There have been other examples of viral proteins with similar functions to E5 interfering with MHC I. It has been shown that HIV-1 Nef binds Vma13, one of the components of the hydrophilic V1 sector of the VATPase (Lu et al., 1998) and causes the accumulation of endocytosed MHC I in the trans-Golgi (Greenberg et al., 1998) . Another small hydrophobic protein, HTLV-1 p12 I , which, like E5, binds to V-ATPase subunit c (Franchini et al., 1993) , causes the intracytoplasmic retention and degradation of MHC I (Johnson et al., 2001) . It thus appears that interference with either sector of the proton pump prevents MHC I localization to the cell surface, either in the exocytic or the endocytic pathway.
We observed that mutant forms of E5 defective for transformation are not capable of down-regulating either surface or total MHC I. Therefore, inhibition of MHC I in primary cells appears to be associated with full transformation, including malformation of Golgi structures. It is tempting to speculate whether the transport or the post-translational modi®cation of cellular proteins involved in cell transformation are similarly aected. Cell surface receptors and adhesion molecules are post-translationally modi®ed and transported to the plasma membrane through the GA (Bellis et al., 1999; Rudd et al., 1999) ; small GTPases of the ras family are either stably or transiently targeted to and post-translationally modi®ed in the endomembranes (Apolloni et al., 2000; Choy et al., 1999; Erickson et al., 1996; Noguchi et al., 1998) . Aberrant glycosylation of glycoproteins by Golgi enzymes often accompanies malignant transformation (Dennis et al., 1999) . Interference with any or all of the proper processing of these proteins could lead to cell transformation and explain the pleiotropic action of E5.
In conclusion, the down-regulation of cell surface MHC I by E5 may directly aect immune recognition and clearance of virally-infected cells. E5 protein is produced early in the infection process, in the virallyinfected basal keratinocytes in the deep layers of the papilloma. Loss of MHC I expression in these cells would lead to a loss of immune recognition by class-I restricted eector cells, which could contribute to viral 1-E5T) . The plus and minus signs above the histogram refer to the degree of cell transformation (for more details concerning the cell lines expressing mutant E5 proteins see Ashra® et al., 2000) persistence and the subsequent development of malignancy.
Materials and methods
Cell lines
Primary embryonic bovine cells (PalF) transformed by papillomavirus oncogenes, with or without E5 from BPV-1 or BPV-4 (1-E5 or 4-E5 respectively), or their mutant forms, have been described before (O'Brien et al., 1999) . In these cells, the combination of BPV-4 E7, E5 from either BPV-1 or BPV-4, and activated ras induces cell transformation but immortalization is conferred by HPV-16 E6 (Pennie et al., 1993) , as the BPV-4 genome does not encode an E6 protein (Jackson et al., 1991) . Brie¯y, normal parental cells are designated PalF or`parental'; cells transformed by E6, E7 and activated ras are designated`no E5' and referred to in the text as`control', and cells transformed as above but with the addition of either E5 protein are designated`E5'. NIH 3T3 mouse ®broblasts transformed by BPV-4 E5 (3T3 4-E5) have also been previously described (O'Brien and Campo, 1998) . Control NIH3T3 cells containing the empty expression vector are designated`3T3'. All cell lines were grown in Dulbecco modi®ed Eagles medium (DMEM) (Life Technologies, UK) containing 10% foetal calf serum (FCS) at 378C in 5% CO 2 .
Construction of recombinant amphotropic retroviruses
The E5 ORF of BPV-4 was ampli®ed by PCR and cloned into the BamHI ± HindIII site of the retroviral vector pLZRSpBMNZ (Pear et al., 1993) . The BPV-4 E5 ORF has at its 5' end a 39 bp sequence encoding the HA epitope (O'Brien et al., 1999) . The construct was propagated in the Max Eciency STBL2 bacterial strain (Life Technologies). Transformations were carried out according to the manufacturer's guidelines and the plasmid was prepared according to the Plasmid Maxi Kit (Qiagen) protocol.
The plasmid was transfected into the packaging cell line Phoenix A (Mann et al., 1983) using the Dotap 1 Liposomal method (Boehringer Manheim). Brie¯y 3 ± 5610 6 cells were seeded into medium¯asks in DMEM/10% FCS and incubated for 24 h at 378C in 5% CO 2 . The cells were then transfected with 10 mg of plasmid DNA in OPTIMEM reduced serum medium (Life Technologies) and incubated at 378C for 12 h. After replacing the medium, the cells were incubated for a further 12 h followed by 48 h at 338C. The supernatant containing the packaged retrovirus was collected and centrifuged to eliminate cell debris. The supernatant was either used directly to infect the target cells or aliquoted and snap frozen for later use.
Infection of PalF cells with recombinant retroviruses
PalF cells (2610 5 ) were seeded into a 25 cm 2 culture¯ask and incubated at 378C. Before infection, the medium was removed and cells were overlaid with equal volumes of viral supernatant and 26 Infection Mix (10 mg/ml polybrene in DMEM, 10% FCS), in a total volume of 1.5 ml. The¯asks were centrifuged at 500 g for 45 min, then incubated at 338C for 6 h, when fresh DMEM, 10% FCS, was added to a ®nal volume of 5 ml. Forty-eight hours or 5 days post infection the cells were harvested for investigation of GA morphology or¯ow cytometry analysis.
Visualization of Golgi apparatus
The GA was visualized by immuno¯uorescent detection using monoclonal antibody (mAb) 4A3 raised against GM130, an integral GA protein (Barr et al., 1998) . Cells were grown until 80% con¯uence in single well chamber slides. After removal of medium, the cells were washed twice with PBS and ®xed with fresh 3% PFA in PBS for 20 min at room temperature. After the PFA ®xation, a second ®xation was performed by dipping the chamber slides in ± 208C methanol for 4 min. The cells were washed three times in PBS, then incubated with mAb 4A3 for 30 min at room temperature and washed as above. The cells were then incubated with AlexaFluor TM 488 goat anti-mouse IgG(H+L) conjugate (Molecular Probes) (1 : 1500 dilution) for 30 min at room temperature. Following a ®nal wash with PBS, the slides were mounted in PBS and analysed under a¯uorescence microscope.
Detection of MHC class I and transferring receptor by FACS
Cells were grown in a 175 cm 2¯a sk to approximately 80% con¯uence. After removal of the medium, the cells were washed once with PBS, then detached from the¯ask with trypsin/EDTA and pelleted at 200 g at room temperature for 5 min. The cell pellet was resuspended in DMEM, 10% FCS, for 1 h at 378C to allow surface antigens to be re-expressed. The cells were washed and re-suspended in PBS, 1% BSA (PBS-B) at 10 7 cells/ml. For the detection of surface MHC I, 100 ml of cells were aliquoted and incubated with an equal volume of anti-bovine MHC class I monomorphic mAb (IL-A19; Bensaid et al., 1989) for PalF cells, and anti-mouse H-2L d mAb (CL9011-A, Cedarlane Laboratories) for NIH 3T3 cells, for 30 min at 48C. For the detection of surface transferrin receptor, cells were incubated with mAb IL-A165 (Naessens and Davis, 1996) . The cells were washed three times in PBS-B, then gently resuspended in 100 ml of PBS-B and incubated with an equal volume of a 1 : 200 dilution of anti-mouse IgG-FITC (Sigma) at 48C for 30 min in the dark. The cells were washed and resuspended in 500 ml PBS-B and analysed by¯ow cytometry. If the¯ow cytometry analysis was not carried out immediately, the cells were resuspended in 500 ml of 3% PFA in PBS and kept at 48C.
For the detection of intracellular MHC I, the cells were ®xed in 3% PFA in PBS for 20 min at room temperature, washed in PBS-B and permeabilized with 0.5% saponin in PBS-B for 30 min at room temperature. Following a further wash in PBS-B, the permeabilized cells were stained with mAb IL-A19 as described above. Samples were examined in a Beckman Coulter EPICS Elite analyser equipped with an ion argon laser with 15 mV of excitation at 488 nm. The data were analysed using Expo 2 software.
Detection of MHC I by Western blots
Cells were removed from the¯asks by trypsinization, washed with PBS, then lysed by sonication in lysis buer (100 mM Tris HCl, pH 7.5, 2% SDS, 20% glycerol) and insoluble material was removed by centrifugation at 20 000 g. Two, 5 and 10 mg of lysate were electrophoresed in 4 ± 12% NuPAGE gels (Invitrogen), and proteins transferred to nitrocellulose membrane (Invitrogen) using a semidry blotting apparatus at 20 v/150 A for 1 h. The membranes were blocked in 5% milk/TBS/Tween 20 (0.05%) at room temperature for 1 h before incubation with mAb IL-A88 which recognizes MHC I heavy chain (Toye et al., 1990) or mAb AB-1 (Calbiochem) speci®c for bovine actin. After repeated washing with TBS/Tween 20 (0.05%) the mem-branes were incubated with anti-mouse Ig-HRP (Amersham Pharmacia Biotech) for mAB IL-A88, and anti-mouse IgM-HRP (Oncogene Calbiochem-Novabiochem International) for mAb AB-1, in 5% milk/TBS/Tween 20 (0.05%) for 1 h at room temperature. The membranes were washed three times with TBS/Tween 20 (0.05%) and bound antibody was detected by enhanced chemoluminescence staining (ECL) (Amersham Pharmacia Biotech).
Detection of MHC I heavy chain transcripts by RT ± PCR RNA was extracted from normal parental PalF cells and transformed cells expressing either 1-E5 or 4-E5 using thè RNeasy 1 Mini kit' (Qiagen) according to the manufacturer's guidelines. Reverse transcription and ampli®cation was carried out in one step using the`Superscript One-Step RT ± PCR' kit (Life Technologies). The MHC I-generic primers BoLaex2F (5'-GGC TCC CAC TC(G/C) (A/C)TG AGG TAT TTC) and BoLaex3R (5'-TCT CCA GGT ATC TGC GGA GCC) were designed to amplify exons 2 and 3 of all classical MHC I heavy chain sequences generating a product of 533 base pairs (bp) from RNA and a 733 bp product from DNA . As a positive control, bovine actin primers were used which generate a 273 bp fragment (Sibbet et al., 2000) .
The RT ± PCR reactions were carried out in 50 ml total volume, MHC I primers were used at a ®nal concentration of 0.2 mM, bovine actin primers at 0.5 mM and RNA was adjusted to 1 mg. A semi-quantitative approach was used where reactions underwent the same RT-cycle (458C for 30 min followed by inactivation of the reverse transcriptase at 948C for 2 min), but the ampli®cation cycles (948C for 30 s, 558C for 1 min, 728C for 1 min) diered by multiples of 5, from 10 to 30 cycles. Fifteen ml of each reaction were run on a 2% agarose gel alongside a 100 bp DNA ladder (Life Technologies) and the amplicon bands were visualized by ethidium bromide staining.
